Efficacy of Transcranial Direct Current Stimulation In Parkinson's Disease MCI (PDMCIStim)
Efficacy of Prefrontal Transcranial Direct Current Stimulation On Cognitive Functions and Electrophysiological Measures In Parkinson's Disease Mild Cognitive Impairment
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Parkinson's Disease (PD) is the second most common neurodegenerative disorder. The period that apparent cognitive deficits exist without disrupting daily life activities is named as Mild Cognitive Impairment (PD-MCI). Treatments were considered to be more efficacious in PD-MCI than PD dementia as relatively less permanent changes in cortical structures occured. No approved treatments exist in PD-MCI and non-pharmacological treatments are under investigation as drugs have considerable amount of adverse effects.
Event Related Potentials (ERP) measurements have the advantages of providing direct and objective evidence of central nervous system functions, imaging of the activity of the cortical areas and being unaffected by motor deficits. ERP parameters were found to be related to cognitive functions and disrupted in PD and PD-MCI. Thus, ERP parameters were suggested to be useful in treatment efficacy assessment.
Transcranial Direct Current Stimulation (tDCS) is a promising non-invasive brain stimulation method. Ameliorating effects of tDCS on cognition and ERPs were observed. Enhancing effects of tDCS on some cognitive deficits were also reported in PD.
Few studies reported the efficacy of both tDCS and physical therapy/cognitive training and none assessed the efficacy of tDCS solely, compared to a sham control group. All studies assessed the efficacy without using electrophysiological measurements that reflect central nervous system functions directly. In this project, the efficacy of tDCS will be compared to a sham tDCS group and be assessed with electrophysiological measurements for the first time.
The study is a double-blind randomized controlled trial. The sample will be consisted of twenty six participants diagnosed as having PD-MCI due to Movement Disorders Society Level 2 criteria. The participants will be assigned to active or sham groups. Then, neuropsychological test performances and ERP parameters during Oddball paradigm and Continuous Performance Test will be measured. Then, participants will be applied ten active or sham sessions of left anodal/right cathodal tDCS over the dorsolateral prefrontal cortex (DLPFC). All measurements will be repeated both immediately and 1-month after the applications.
Succinctly, the aim of this project is to assess the effect of ten sessions left anodal/right cathodal tDCS over the DLPFC on cognitive functions and electrophysiological parameters in PD-MCI.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
-
Istanbul, Turquie
- Istanbul University
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Clinical diagnosis of PD with at least two of the four diagnostic criteria for PD (tremor, rigidity, bradykinesia, and postural instability) in accordance with the United Kingdom Parkinson's Disease Society Brain Bank Diagnostic Criteria, issued by a neurologist specializing in movement disorders;
- Disease staging between I and III, according to the modified Hoehn and Yahr scale;
- Clinical diagnosis of PD- MCI in accordance with Level 2 Movement Disorders Society- Task Force diagnostic criteria;
- An unchanged stable and optimal regimen of dopaminergic medication for at least one month before study entry and able to continue on a stable regimen for the duration of the study;
- Ability to provide written informed consent;
- 5 or more years of education;
- Right-hand dominancy;
- Not taking any psychoactive medications before the previous month of the study and for the duration of the study;
- Naïve to tDCS.
Exclusion Criteria:
- Diagnosis or evidence of secondary or atypical parkinsonism;
- Patients with dementia;
- Less than 5 years of education;
- Previous history of surgical intervention for PD such as deep brain stimulation (DBS);
- Diagnosis of active major depressive disorder, psychotic disorders, bipolar disorder, alcohol use disorder and substance use disorders;
- Any history of any clinically significant neurological disorder, including organic brain disease, epilepsy, stroke, brain lesions, multiple sclerosis, previous neurosurgery, or personal history of head trauma that resulted in loss of consciousness for > 5 minutes and retrograde amnesia for > 30 minutes;
- Significant hearing loss or visual impairment;
- Diagnosis of any serious or uncontrolled medical condition such as chronic obstructive pulmonary disease, congestive heart failure or renal failure;
- Skin diseases that could potentially cause irritations under electrodes
- Patients missing two consecutive protocol sessions;
- Illiteracy, deficient language or refusal to participate or being not able to follow instructions or complete study tasks;.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Double
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Comparateur actif: Active
Left anodal/right anodal transcranial direct current stimulation over the dorsolateral prefrontal cortex
|
Participants will receive a total of 10 stimulation sessions on 5 consecutive days (twice a day with 3-4 hours interval).
During each session, 2 milliAmpers (mA) of active or sham tDCS will be applied for 20 minutes over the dorsolateral prefrontal cortex (left anodal/right anodal).
Autres noms:
|
|
Comparateur factice: Sham
Sham transcranial direct current stimulation over the dorsolateral prefrontal cortex
|
Participants will receive a total of 10 stimulation sessions on 5 consecutive days (twice a day with 3-4 hours interval).
During each session, 2 milliAmpers (mA) of active or sham tDCS will be applied for 20 minutes over the dorsolateral prefrontal cortex (left anodal/right anodal).
Autres noms:
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Changes in response conflict in the Stroop Test during the study period
Délai: Up to one month
|
The stroop effect consists of the semantic and the response conflict.
Response conflict (time in milliseconds) is obtained by subtracting the semantic conflict (time in milliseconds obtained in the second step of the protocol) from the stroop effect (time in milliseconds obtained in the first step of the protocol).
Minimum time difference is 0 and maximum time difference is 100 milliseconds.
Lower time differences indicate better performance and higher time differences indicate worse performance.
|
Up to one month
|
|
Change in the verbal fluency performance during the study period
Délai: Up to one month
|
Verbal fluency is a test that measure multiple domains of cognition such as executive functions and language functions.
Letter Verbal Fluency assesses the number of words beginning with certain letters that participants can generate within 60 seconds, the Category Verbal Fluency assesses the number of words within particular categories participants can generate within 60 seconds.
Minimum score is 0 and maximum score is 80. Lower scores indicate worse performance and higher scores indicate better performance.
|
Up to one month
|
|
Changes in Trail Making A Test performance during the study period
Délai: Up to one month
|
Trail Making A Test is a widely used as a quick and easy to administer measure of attention.
Lower reaction times indicate better performance and higher reaction times indicate worse performance.
Minimum time is 10 milliseconds and maximum time is 150 milliseconds.
|
Up to one month
|
|
Changes in digit span during the study period
Délai: Up to one month
|
The Digit Span test is a measure of verbal short-term/working memory. Subjects must recall all digits either in forward (digit span forward) or backward (digit span backward) order. Digit span forward total score: 0-10; higher score indicate better performance, digit span backwards total score: 0-10; higher score indicate better performance |
Up to one month
|
|
Changes in delayed recall performance during the study period
Délai: Up to one month
|
Memory performance was assessed using delayed recall (number of units recalled) on the Wechsler Memory Scale (WMS-IV) logical memory (story recall) test.
Scores represent a sum of recalled units of two different stories after a 30 minute delay.
Total scores range from 0 to 50 (0-25 for each story) with higher scores reflecting better memory performance.
|
Up to one month
|
|
Changes in verbal memory processes performance during the study period
Délai: Up to one month
|
The Verbal Memory Processes Test is a 15-word word-list learning test with a 40-minute delayed recall addition based on the Rey Auditory Verbal Learning Test which gives the opportunity to evaluate the processes of working memory, learning or acquiring knowledge, retention of information, and recalling. It consists of immediate recall, learning score and a 40-min delayed recall test, followed by total recall. Higher scores indicate better performance in all indexes of the test. Minimum scores are 0 and maximum scores are 15 for immediate recall, delayed recall and total recall and 150 for learning score, respectively. |
Up to one month
|
|
Changes in face recognition performance during the study period
Délai: Up to one month
|
Benton Facial Recognition Test is a common test assessing visuo-spatial functions.
It was developed by Benton in 1969.
It is standardized to determine the capacity to identify and distinguish unrecognized human faces.
This test consists of 22 pages of A4 size and there are face pictures on these pages.
Only one page of pages is numbered.
There is a stimulant picture on pages with no page numbers.
Numbered pages have 6 pictures to select from among the responses.
The application period of the test is 5-15 minutes and the time factor is not evaluated separately.
Higher scores indicate better performance and lower scores indicate worse performance.
Minimum score is 0 and maximum score is 54.
|
Up to one month
|
|
Changes in judgment of line orientation performance during the study period
Délai: Up to one month
|
A test of visuospatial judgement.
The test measured the participant's ability to match the angle and orientation of lines in space.
There were 30 trial in total.
Correct response in a trial was awarded one point.
Minimum score is 0 and maximum score is 30.
Higher scores represent better performances.
|
Up to one month
|
|
Changes in the naming performance during the study period
Délai: Up to one month
|
The naming performance will be measured by the Boston Naming Test Short Form and Responsive Naming Test.
Boston Naming Test consists of 45 pictures to be named.
Minimum score is 0 and maximum score is 45.
Higher scores indicate better performance and lower scores indicate worse performance.
In the Responsive Naming Test, participants answer the questions such as "What do women apply to their lips?"
Minimum score is 0 and maximum score is 10.
Higher scores indicate better performance and lower scores indicate worse performance.
|
Up to one month
|
|
Changes in amplitudes (in microvolts) for parameters from the ERP tests during the study period for parameters from the ERP tests during the study period
Délai: Up to one month
|
Amplitudes (in microvolts) for the following parameters from the ERP tests will be collected as primary endpoints:N1, P3 and other common wave forms for both Two-tone auditory oddball paradigm and Continuous Performance Test ERP paradigms.
|
Up to one month
|
|
Changes in detection sensitivity from the behavioral responses during the Two-tone auditory oddball and Continuous Performance Test ERP paradigms during the study period
Délai: Up to one month
|
Detection sensitivity from Signal Detection Theory (d', calculated as [zFA - zHR], where z is the inverse of the standard normal cumulative distribution, FA is the false-alarm rate [the proportion of responses made to stimuli that were not targets], and HR is the hit rate [the proportion of correct identifications of target stimuli]) during the Two-tone auditory oddball and Continuous Performance Test ERP paradigms will be measured.
|
Up to one month
|
|
Changes in reaction times from the behavioral responses during the Two-tone auditory oddball and Continuous Performance Test ERP paradigms during the study period
Délai: Up to one month
|
Reaction times for the correct behavioral responses during the Two-tone auditory oddball and Continuous Performance Test ERP paradigms will be measured.
|
Up to one month
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Correlation between changes in behavioral measures and changes in amplitudes of ERP components
Délai: Up to one month
|
Correlation between changes in detection sensitivity from the behavioral responses and changes in amplitudes of ERP components during the Two-tone auditory oddball and Continuous Performance Test ERP paradigms during the study period
|
Up to one month
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Serkan Aksu, Istanbul University
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 2018-055
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
produit fabriqué et exporté des États-Unis.
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Maladie de Parkinson
-
ProgenaBiomeRecrutementMaladie de Parkinson | Maladie de Parkinson avec démence | Syndrome de Parkinson-Démence | Maladie de Parkinson 2 | Maladie de Parkinson 3 | Maladie de Parkinson 4États-Unis
-
National Heart, Lung, and Blood Institute (NHLBI)ComplétéMaladie de Parkinson 6, début précoce | Maladie de Parkinson (autosomique récessive, début précoce) 7, humain | Maladie de Parkinson autosomique récessive, début précoce | Maladie de Parkinson, début précoce autosomique récessif, digénique, Pink1/Dj1États-Unis
-
Ahram Canadian UniversityRecrutementMaladie de Parkinson | Parkinson | Maladie de Parkinson et parkinsonismeEgypte
-
Samuel Vilchez, PhDNational Autonomous University of Nicaragua; Wake Forest University; GID BIO... et autres collaborateursComplétéMaladie de Parkinson et parkinsonisme | Maladie de Parkinson idiopathiqueNicaragua
-
King's College LondonGlaxoSmithKlineComplétéMaladie de Parkinson | Maladie de Parkinson idiopathique | Maladie de Parkinson, PARK8Royaume-Uni
-
Ohio State UniversityComplétéLa maladie de Parkinson | Maladie de Parkinson | Maladie de Parkinson idiopathique | Maladie de Parkinson idiopathique | Maladie de Parkinson, idiopathique | Maladie de Parkinson, idiopathiqueÉtats-Unis
-
National Yang Ming UniversityInconnueMaladie de Parkinson à début précoce | Maladie de Parkinson à un stade précoce
-
Assistance Publique - Hôpitaux de ParisFrance Parkinson AssociationInconnueContrôles sains | Maladie de Parkinson avec mutation LRRK2 | Maladie de Parkinson sans mutation LRRK2France
-
University of Campania "Luigi Vanvitelli"Neuromed IRCCSInconnueMaladie de Parkinson secondaireItalie
-
Medical College of WisconsinRetiré